Dementia Part 2 Flashcards
individuals in this stage of dementia experience no memory problems, and nothing is evident to a health care professional during a medical interview
stage 1
no cognitive impairment
individuals in this stage of dementia feel like they have memory lapses, esp in forgetting familiar words or names or the location of keys or other everyday objects. these problems are NOT evident during medical exam or apparent to friends or family.
stage 2
very mild cognitive decline
in this stage of dementia, friends, family and coworkers begin to notice deficiencies. problems with memory or concentration MAY be measurable in clinical testing
stage 3
mild cognitive decline
early stage alzheimer’s can be diagnosed in some
at this stage, a careful medical interview detects clear-cut deficiencies. the affected individual may seem subdued or withdrawn, especially in mentally or socially challenging situations
stage 4
moderate cognitive decline
mild or early-stage AD
at this stage, major gaps in memory and deficits in cognitive function emerge. some assistance with day-to-day activities becomes essential
stage 5
moderately cognitive decline (moderate or mid-stage AD)
at this stage, memory difficulties continue to worsen, significant personality changes may emerge, and affected individuals need extensive help with customary daily activities
stage 6
severe cognitive decline (mod-severe or mid-stage AD)
at this stage, individuals lose the ability to respond to their environment, to speak, and ultimately control movement
stage 7
very severe cognitive decline (severe or late-stage AD)
how often should a patient with AD be seen by a medical provider?
every 3-6 months
what is our cholinesterase inhibitor used to manage alzheimers?
aricept (donepezil)
is the use of aricept used in the following diseases?
1) vascular dementia
2) lewy body dementia
3) parkinson dementia
4) frontotemporal dementia
1) vascular = NO
2) lewy body = beneficial for behavioral disturbance
3) parkinson = rivastigmine for mild-moderate dementia (also chilinesterase inhibitor)
4) frontotemporal = NO and may WORSEN agitation
what drug is considered neuroprotective and its effect is to reduce the glutamate-mediate excitotoxicity seen in treatment with aricept?
memantine
has memantine shown modest benefit in cognition, ADLS, and behavior in AD?
yes
only give for moderate-severe AD
what vitamin has been shown to maybe lower the rate of decline in AD, but has NO evidence of cognitive improvement in AD?
vitamin E
but i guess its not longer recommended = evidence of increased mortality with HD supplementation
_______ may lower the rate of decline, but has no evidence of cognitive improvement of AD
selegiline
your patient wants their mother to take gingko biloba because they saw it helps with AD. what do you tell them?
no benefit in slowing cognitive decline in MCI